Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition
View abstract on PubMed
Summary
This summary is machine-generated.Sirtuin 1 (SIRT1) suppresses nasal polyp formation by inhibiting hypoxia-induced epithelial-to-mesenchymal transition. This finding suggests SIRT1 is a potential therapeutic target for nasal polyps in chronic rhinosinusitis.
Area Of Science
- Otorhinolaryngology
- Molecular Biology
- Cell Biology
Background
- Nasal polyps (NPs) are associated with refractory chronic rhinosinusitis (CRS).
- Hypoxia-inducible factor (HIF) 1 promotes nasal polypogenesis via epithelial-to-mesenchymal transition (EMT).
- Sirtuin 1 (SIRT1), a histone deacetylase, is known to suppress HIF-1 activity.
Purpose Of The Study
- To investigate the role of SIRT1 in the development of nasal polyps.
- To determine if SIRT1 can inhibit HIF-1-induced EMT in nasal tissues.
Main Methods
- Utilized murine models of nasal polypogenesis.
- Employed immunohistochemistry, immunoblotting, and immunoprecipitation.
- Analyzed sinonasal tissues from patients with CRS with and without NPs.
Main Results
- SIRT1 overexpression or activation reduced NP formation and reversed hypoxia-induced EMT in human nasal epithelial cells.
- SIRT1 was downregulated in nasal polyps from CRS patients.
- SIRT1 inhibition exacerbated polyp burden in transgenic mice.
Conclusions
- SIRT1 plays a protective role against nasal polyp formation.
- Inhibition of HIF-1-induced EMT by SIRT1 is a key mechanism.
- Nasal epithelial SIRT1 represents a potential therapeutic target for NPs.